These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17258405)

  • 21. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.
    Horrée N; van Diest PJ; Sie-Go DM; Heintz AP
    Hum Pathol; 2007 Aug; 38(8):1232-8. PubMed ID: 17490724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
    Song H; Li C; Lu R; Zhang Y; Geng J
    Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. bcl-2 expression in endometrial hyperplasia and carcinoma.
    Niemann TH; Trgovac TL; McGaughy VR; Vaccarello L
    Gynecol Oncol; 1996 Dec; 63(3):318-22. PubMed ID: 8946865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RB protein expression in human endometrial carcinomas--an immunohistochemical study.
    Semczuk A; Schneider-Stock R; Miturski R; Skomra D; Tomaszewski J; Roessner A; Jakowicki JA
    Pathol Res Pract; 2000; 196(1):41-6. PubMed ID: 10674271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
    Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
    Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital morphometry of cytologic aspirate endometrial samples.
    Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
    Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
    Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
    J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma.
    Chan WK; Mole MM; Levison DA; Ball RY; Lu QL; Patel K; Hanby AM
    J Pathol; 1995 Nov; 177(3):241-6. PubMed ID: 8551385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
    Amalinei C; Cianga C; Balan R; Cianga P; Giusca S; Caruntu ID
    Ann Anat; 2011 Feb; 193(1):43-55. PubMed ID: 21145716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and significance of heat shock protein 70, 90 in endometrial carcinomas].
    Bai XX; Chen YQ; Xin XY; Wang WD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):38-40. PubMed ID: 15132902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DFF45 expression in ovarian endometriomas.
    Banas T; Skotniczny K; Basta A
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):87-91. PubMed ID: 19535198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.